Today: 10 June 2026
Browse Category

LSE:SN. 1 December 2025 - 2 December 2025

Smith & Nephew (SNN) Stock Forecast 2026: Q3 2025 Results, $500m Buyback and New Board Signals

Smith & Nephew (SNN) Stock Forecast 2026: Q3 2025 Results, $500m Buyback and New Board Signals

Smith & Nephew shares traded near $33.28 in early U.S. trading on December 1, up 29% from a year ago but 14% below their recent high. Q3 revenue reached $1.50 billion, missing market expectations by $10 million and sending the stock down 9% that day. The company’s turnaround plan is nearly complete, with management reaffirming 2025 revenue growth guidance of around 5%. Market cap stands at about $14.1 billion.
1 December 2025
·

Stock Market Today

  • Parabilis Medicines Raises $670 Million in Record-Breaking Biotech IPO
    June 10, 2026, 5:42 AM EDT. Parabilis Medicines raised a record $670 million in its initial public offering (IPO), making it the largest biotech listing to date. The cancer-focused company sold 33.5 million shares at $20 each, with a potential to increase proceeds by $100 million via underwriters' option. Parabilis aims to advance its lead candidate zolucatetide, targeting desmoid tumors, familial adenomatous polyposis, and other cancers, supported by FDA fast-track designation. The company also plans to invest $190 million in developing other drug candidates. Led by CEO Mathai Mammen, Parabilis leverages a novel helicon peptide platform to target previously undruggable proteins. The firm has secured substantial funding rounds since 2021 and recently partnered with Regeneron in a deal including $50 million upfront and $75 million equity investment.

Latest articles

DraftKings (DKNG) Moves After Prediction-Market News — Traders Focus on Stock

DraftKings (DKNG) Moves After Prediction-Market News — Traders Focus on Stock

10 June 2026
DraftKings shares soared 11.34% to $27.59 after revealing a 24% month-over-month jump in annualized consumer volume to $1.3 billion and a 34% rise in total volume traded to $3.1 billion in its Predictions product for May, based on preliminary, unaudited data, outpacing a falling Nasdaq and spotlighting investor focus on the product’s revenue potential and DraftKings’ strategic push.
Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

10 June 2026
Micron shares fell 1.5% to $935.89 as the AI-chip rally cooled, despite bullish analyst calls and price targets up to $1,625; investors await the June 24 earnings report to see if tight memory chip supply and AI demand can sustain the stock’s trillion-dollar valuation amid broader market jitters and shifting sentiment.
Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Dips Premarket After 2.7 Million-Share Filing

10 June 2026
SoFi Technologies traded near $16.47 in early premarket, little changed as investors weighed its AI and digital asset product push against a risk-off market mood, with no fresh earnings news and inflation data looming that could impact rates, loan demand, and fintech valuations.
Ondas Dips Premarket After 2.7 Million-Share Filing

SoFi Stock Holds Ahead of Pre-Market Test as Wall Street Grows Defensive

10 June 2026
Rolls-Royce shares rebounded 1.5% in London after Tuesday’s 2.68% drop, as investors weighed fresh airline criticism over engine delays against the company’s reaffirmed 2026 profit and cash flow guidance; CEO Tufan Erginbilgic said Rolls had a “strong start to the year,” but risks remain if airline pressure leads to higher costs or slower cash conversion.
LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Go toTop